These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 31782368)

  • 21. Single-Agent and Fixed-Dose Combination HIV-1 Protease Inhibitor Drugs in Fission Yeast (
    Zhang J; Vernon K; Li Q; Benko Z; Amoroso A; Nasr M; Zhao RY
    Pathogens; 2021 Jun; 10(7):. PubMed ID: 34202872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
    Majerová-Uhlíková T; Dantuma NP; Lindsten K; Masucci MG; Konvalinka J
    J Clin Virol; 2006 May; 36(1):50-9. PubMed ID: 16527535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a new cell line inducibly expressing HIV-1 protease for performing safe and highly sensitive screening of HIV protease inhibitors.
    Fuse T; Watanabe K; Kitazato K; Kobayashi N
    Microbes Infect; 2006 Jun; 8(7):1783-9. PubMed ID: 16815068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A drug discovery platform: a simplified immunoassay for analyzing HIV protease activity.
    Kitidee K; Nangola S; Hadpech S; Laopajon W; Kasinrerk W; Tayapiwatana C
    J Virol Methods; 2012 Dec; 186(1-2):21-9. PubMed ID: 22846787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges.
    Voshavar C
    Curr Top Med Chem; 2019; 19(18):1571-1598. PubMed ID: 31237209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
    Getz RA; Kwak G; Cornell S; Mbugua S; Eberhard J; Huang SX; Abbasi Z; de Medeiros AS; Thomas R; Bukowski B; Dranchak PK; Inglese J; Hoffman CS
    Cell Signal; 2019 Aug; 60():114-121. PubMed ID: 31026495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Cloning and Characterization of Small Viral Genome in Fission Yeast.
    Li G; Zhao RY
    Methods Mol Biol; 2018; 1721():47-61. PubMed ID: 29423846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yeast for virus research.
    Zhao RY
    Microb Cell; 2017 Sep; 4(10):311-330. PubMed ID: 29082230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Darunavir Stands Up as Preferred HIV Protease Inhibitor.
    Mallolas J
    AIDS Rev; 2017; 19(2):105-112. PubMed ID: 28664942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fission yeast cell-based system for multidrug resistant HIV-1 proteases.
    Benko Z; Liang D; Li G; Elder RT; Sarkar A; Takayama J; Ghosh AK; Zhao RY
    Cell Biosci; 2017; 7():5. PubMed ID: 28096973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast.
    Li G; Poulsen M; Fenyvuesvolgyi C; Yashiroda Y; Yoshida M; Simard JM; Gallo RC; Zhao RY
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E376-E385. PubMed ID: 28049830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Protease in the Fission Yeast Schizosaccharomyces pombe.
    Benko Z; Elder RT; Li G; Liang D; Zhao RY
    PLoS One; 2016; 11(3):e0151286. PubMed ID: 26982200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expedient screening for HIV-1 protease inhibitors using a simplified immunochromatographic assay.
    Kitidee K; Khamaikawin W; Thongkum W; Tawon Y; Cressey TR; Jevprasesphant R; Kasinrerk W; Tayapiwatana C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():153-158. PubMed ID: 26490422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of HIV-1 genome in fission yeast Schizosaccharomyces pombe.
    Nkeze J; Li L; Benko Z; Li G; Zhao RY
    Cell Biosci; 2015; 5():47. PubMed ID: 26309721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
    Chetty S; Bhakat S; Martin AJ; Soliman ME
    J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fission yeast-based high-throughput screens for PKA pathway inhibitors and activators.
    de Medeiros AS; Kwak G; Vanderhooft J; Rivera S; Gottlieb R; Hoffman CS
    Methods Mol Biol; 2015; 1263():77-91. PubMed ID: 25618337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yeast as a potential vehicle for neglected tropical disease drug discovery.
    Denny PW; Steel PG
    J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in non-peptidomimetic HIV protease inhibitors.
    Pang X; Liu Z; Zhai G
    Curr Med Chem; 2014 Jun; 21(17):1997-2011. PubMed ID: 24533811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterocyclic HIV-protease inhibitors.
    Calugi C; Guarna A; Trabocchi A
    Curr Med Chem; 2013; 20(30):3693-710. PubMed ID: 23746271
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.